Several therapeutic nanoparticle (NPs) platforms, such as liposomes, polymers, and albumin NPs have already been utilized for cancer treatment to improve a drug’s solubility and stability, alter systemic exposure, promote tumor infiltrations, and enhance the uptakes of tumor cells. This evidence concerns the gene ALB and neoplasm.